Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients with advanced solid tumors, including ovarian cancer, endometrial cancer, and ...
Biotech funding surges as companies like Pelage, Kardigan, and Kailera secure millions to innovate treatments for hair loss, ...
Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadershipPhase 1/2a trial now expected to begin in ...
Q3 2025 Earnings Call Transcript October 14, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, ...
Novo Nordisk acquires Akero Therapeutics for $5.2B to boost its metabolic disease pipeline with EFX. Check out what this ...
Tammy McDevitt didn't know what lobular cancer was until she got her diagnosis; now with treatment behind her, she shares ...
(NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in ...
5don MSN
Family claim 'corrupt officers and organised crime groups have flooded' prison where man died
They were speaking via lawyers after the inquest into their relative's death concluded on Thursday. The family claim measures ...
Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.
Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients ...
Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback